Pharmaceutical Excipients Market Size Worth USD 20.56 Billion By 2034 | CAGR: 6.2%
The global pharmaceutical excipients market size is expected to reach USD 20.56 billion by 2034, according to a new study by Polaris Market Research. The report “Pharmaceutical Excipients Market Size, Share, Trends, Industry Analysis Report: By Product (Inorganic Chemicals and Organic Chemicals), By Formulation, By Functionality, By End Use, and By Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Pharmaceutical excipients are inactive substances that aid in the formulation of drugs to support the active pharmaceutical ingredient (API) in achieving stability, bioavailability, and proper drug delivery. Excipients have different roles, including acting as fillers, binders, disintegrants, preservatives, and coating materials, to ensure the proper production and delivery of drugs. Excipients are essential for improving drug solubility, controlling drug release mechanisms, and enhancing patient compliance, making them indispensable in pharmaceutical production.
The growth of the pharmaceutical excipients industry is driven by rising pharmaceutical production and advancements in drug delivery systems. The market also benefits from the rising demand for generic and biologic drugs. The development of the pharmaceutical industry, especially in emerging countries, is opening new avenues for excipient suppliers.
Trends in the pharmaceutical excipients industry include the adoption of multifunctional excipients and the shift towards naturally derived excipients. The focus on personalized medicine is also shaping the market landscape. In addition, stringent regulations imposed by regulatory bodies to ensure the safety and efficacy of excipients are encouraging innovation and quality improvements in excipients. Due to ongoing innovations in drug formulations and the growing needs of the healthcare sector, the demand for pharmaceutical excipients is expected to be high.
Pharmaceutical Excipients Market Report Highlights
- By product, the organic chemicals segment holds a larger pharmaceutical excipients market share. This is due to their extensive use in drug formulations and increasing demand naturally derived excipients.
- By formulation, the tablets formulation segment is expected to witness significant growth. The segment’s growth is supported by the ease of manufacturing and the long shelf life of tablet pharmaceutical excipients.
- Europe dominated the market revenue share in 2025. This is due to its well-established pharmaceutical industry and continuous advancements in drug formulation technologies.
- The Asia Pacific pharmaceutical excipients market is experiencing rapid growth. Expanding pharmaceutical manufacturing and favorable government policies are driving the regional market growth.
- The pharmaceutical excipients market features several prominent companies actively contributing to the industry. These include Lubrizol Corporation; Archer Daniels Midland Company; DuPont de Nemours, Inc.; BASF SE; Evonik Industries AG; Ashland Global Holdings Inc.; Roquette Frères; Kerry Group plc; Croda International Plc; DFE Pharma; JRS Pharma; Colorcon, Inc.; MEGGLE GmbH & Co. KG; Wacker Chemie AG; and Associated British Foods plc.
Where is the Market Headed?
The market for pharmaceutical excipients is headed towards excipients of better quality and functionality, which not only act as carriers for the main drug but also work towards enhancing stability, taste, shelf life, and ease of manufacture. With the increasing need for generics, biologics, and patient-friendly formulations such as orally disintegrating tablets and injectables, manufacturers are working towards ensuring a stable supply, quality, and documentation. There is also an increasing trend towards co-processed and ready-to-use excipients that could help in reducing costs. The market is therefore heading towards a shift from raw materials to value-added solutions.
What Does the Pharmaceutical Excipients Report Reveal?
- What is the global market size and CAGR for the market during 2026–2034?
- Which factors are contributing to the industry expansion?
- Who are the key industry players? What is their relative position in terms of competitive positioning?
- How do different products, such as inorganic chemicals and organic chemicals, influence the market landscape?
- How does the market differ in terms of product, formulation, functionality, end use, and geography? Which is the leading formulation?
- What are the opportunities in different regional markets, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
- What are the emerging technologies and innovations in the market?
Request a free sample copy or read the full market insights : Patient Handling Equipment Market Report
Polaris Market Research has segmented the pharmaceutical excipients market report based on product, formulation, functionality, end use, and region:
By Product Outlook (Revenue – USD Billion, 2021–2034)
- Inorganic Chemicals
- Organic Chemicals
By Formulation Outlook (Revenue – USD Billion, 2021–2034)
- Tablets Formulation
- Capsules Formulation
- Parental Formulation
- Liquid Formulation
- Oral Formulation
By Functionality Outlook (Revenue – USD Billion, 2021–2034)
- Blinders
- Fillers & Diluents
- Suspending & Viscosity agents
- Preservatives
- Flavoring Agents & Sweeteners
- Coating Agents
By End Use Outlook (Revenue – USD Billion, 2021–2034)
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- Research Institutions
By Regional Outlook (Revenue – USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
